The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(2,3-dihydrobenzo[b][1,4]dioxane-6-yl)-N-phenyl-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazole-1-carbothioamide ID: ALA4286889
PubChem CID: 145990447
Max Phase: Preclinical
Molecular Formula: C22H19N3O2S2
Molecular Weight: 421.55
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: S=C(Nc1ccccc1)N1N=C(c2cccs2)CC1c1ccc2c(c1)OCCO2
Standard InChI: InChI=1S/C22H19N3O2S2/c28-22(23-16-5-2-1-3-6-16)25-18(14-17(24-25)21-7-4-12-29-21)15-8-9-19-20(13-15)27-11-10-26-19/h1-9,12-13,18H,10-11,14H2,(H,23,28)
Standard InChI Key: DJWUWQKHGCJTLN-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
8.7034 -5.1711 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8829 -5.1608 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6171 -5.9370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2739 -6.4285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9453 -5.9534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1144 -4.4613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9362 -4.4672 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7084 -3.7483 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.9099 -6.3493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3480 -3.7613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1698 -3.7671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5844 -3.0560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1784 -2.3430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3579 -2.3411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9460 -3.0470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8514 -7.4444 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.1423 -7.0358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1423 -6.2145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8514 -5.8059 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5605 -6.2145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5605 -7.0358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4332 -5.8059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7207 -6.2152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7200 -7.0358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4332 -7.4444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1610 -6.0215 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.6158 -6.6322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0281 -7.3394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8280 -7.1657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 1 0
6 8 2 0
1 6 1 0
3 9 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
7 10 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
16 21 1 0
22 23 1 0
23 24 2 0
24 25 1 0
17 25 2 0
18 22 2 0
5 23 1 0
9 26 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 9 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 421.55Molecular Weight (Monoisotopic): 421.0919AlogP: 5.07#Rotatable Bonds: 3Polar Surface Area: 46.09Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.99CX Basic pKa: 0.31CX LogP: 5.12CX LogD: 5.12Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.60Np Likeness Score: -1.57
References 1. Li HL, Su MM, Xu YJ, Xu C, Yang YS, Zhu HL.. (2018) Design and biological evaluation of novel triaryl pyrazoline derivatives with dioxane moiety for selective BRAFV600E inhibition., 155 [PMID:29940463 ] [10.1016/j.ejmech.2018.06.043 ]